Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MERTK | Q12866 | 9/20 | 0.50 |
| ▸ | FLT3 | P36888 | 8/20 | 0.50 |
| ▸ | TYRO3 | Q06418 | 8/20 | 0.50 |
| ▸ | GAS6 | Q14393 | 8/20 | 0.50 |
| ▸ | PDE4A | P27815 | 1/20 | 0.49 |
| ▸ | AXL | P30530 | 1/20 | 0.48 |
| ▸ | CTSS | P25774 | 1/20 | 0.47 |
| ▸ | CTSK | P43235 | 1/20 | 0.47 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.47 |
| ▸ | DNM2 | P50570 | 1/20 | 0.44 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10345298 | 0.95 | KMT2A (0.49) | MERTKFLT3TYRO3GAS6PDE4A | |
| SCHEMBL14725039 | 0.93 | TLR7 (0.46) | MERTKFLT3TYRO3GAS6PDE4A | |
| SCHEMBL6920873 | 0.91 | PDE4A (0.59) | MERTKFLT3TYRO3GAS6PDE4A | |
| SCHEMBL14522578 | 0.88 | NPSR1 (0.44) | MERTKFLT3TYRO3GAS6PDE4A | |
| SCHEMBL8075603 | 0.84 | KMT2A (0.40) | MERTKFLT3TYRO3GAS6PDE4A | |
| SCHEMBL14544597 | 0.83 | KCNH3 (0.47) | MERTKTYRO3GAS6PDE4ACTSS | |
| SCHEMBL1087677 | 0.81 | MERTK (0.45) | MERTKFLT3TYRO3GAS6AXL | |
| SCHEMBL30467037 | 0.81 | MERTK (0.45) | MERTKFLT3TYRO3GAS6AXL | |
| Cyromazine SCHEMBL15992192 | 0.81 | MERTK (0.47) | MERTKFLT3TYRO3GAS6AXL | |
| SCHEMBL8077213 | 0.79 | KMT2A (0.41) | MERTKFLT3TYRO3GAS6DNM2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8198387-B2 | Proton-conducting compound and proton-conducting polymer | NIPPON STEEL CHEMICAL CO., LTD. (JP) | 2012-06-12 | — | — | US | disclosed |
| US-8198387-B2 | Proton-conducting compound and proton-conducting polymer | NIPPON STEEL CHEMICAL CO., LTD. (JP) | 2012-06-12 | — | — | US | disclosed |
| US-20100063249-A1 | PROTON-CONDUCTING COMPOUND AND PROTON-CONDUCTING POLYMER | NIPPON STREEL CHEMICAL CO., LTD (JP) | 2010-03-11 | — | — | US | disclosed |
| US-20100063249-A1 | PROTON-CONDUCTING COMPOUND AND PROTON-CONDUCTING POLYMER | NIPPON STREEL CHEMICAL CO., LTD (JP) | 2010-03-11 | — | — | US | disclosed |
| EP-2078715-A1 | PROTON CONDUCTING COMPOUND AND PROTON CONDUCTING POLYMER | Nippon Steel Chemical Co., Ltd. (JP) | 2009-07-15 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100063249-A1 | PROTON-CONDUCTING COMPOUND AND PROTON-CONDUCTING POLYMER | HRH3, H1-3, H1-4 | MERTK 3968/4885FLT3 1470/4885TYRO3 2621/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.